The TBI Socket market is principally divided by application, a taxonomy that drives demand allocation across clinical settings. Upper‑limb rehabilitation accounts for the largest share, roughly 35 % of total revenue, as it addresses post‑traumatic motor deficits in the shoulder, elbow and hand. Lower‑limb rehabilitation follows with an estimated 30 % contribution, reflecting the need for gait‑restoring sockets for ankle‑foot orthoses and knee‑brace interfaces. Spinal‑cord injury applications represent about 20 % of the market, where sockets are integrated into exoskeletal platforms to support trunk stability and lower‑extremity loading. Neurological‑disorder use, including stroke and multiple sclerosis, comprises the remaining 15 %, driven by adaptive socket designs that accommodate fluctuating spasticity and muscle tone. These four application segments collectively define the TBI Socket segmentation framework and determine investment priorities, as each segment’s growth rate is tied to the prevalence of the underlying condition and reimbursement pathways. Forecasts through 2030 project a compound annual growth rate (CAGR) of 6.2 % for the upper‑limb segment, outpacing the overall market, while lower‑limb and spinal‑cord segments are expected to grow at 5.4 % and 4.9 % respectively, reflecting differential adoption of sensor‑fusion technologies.